Suppr超能文献

腹部癌症患者肠梗阻的管理

Management of bowel obstruction in patients with abdominal cancer.

作者信息

Woolfson R G, Jennings K, Whalen G F

机构信息

Department of Surgery, University of Connecticut School of Medicine, Farmington, USA.

出版信息

Arch Surg. 1997 Oct;132(10):1093-7. doi: 10.1001/archsurg.1997.01430340047006.

Abstract

OBJECTIVE

To determine the value of operation in patients with bowel obstruction caused by recurrent abdominal cancer.

DESIGN

Retrospective case review.

SETTING

The University of Connecticut Health Center, Farmington.

PATIENTS

Ninety-eight patients admitted with a diagnosis of bowel obstruction and malignant neoplasm between November 1, 1987, and June 30, 1995.

RESULTS

Data for 75 patients who developed a bowel obstruction within 5 years of a malignant diagnosis were analyzed. Forty-six patients (61%) were treated operatively and 29 (39%) were treated nonoperatively. The operative group included 32 patients (70%) whose obstruction was caused by carcinomatosis; 6 (19%) of these 32 patients had had at least 1 episode of previous obstruction requiring hospitalization. They had a 22% in-hospital mortality, stayed an average of 21 days in the hospital, and survived 7 +/- 6 months (mean +/- SD) after discharge; 5 (16%) had at least 1 episode of postoperative obstruction that required hospitalization. After discharge from the hospital, 53% had an excellent or good quality of life (assessed retrospectively). Of the 29 patients in the nonoperative group, 16 (55%) had carcinomatosis. These 16 patients had a 38% in-hospital mortality (6 of 16), stayed an average of 10 days in the hospital, and survived a mean of 13 +/- 9 months; 3 (19%) had at least 1 episode of recurrent obstruction requiring hospitalization. After discharge from the hospital, 6 (37%) had an excellent or good quality of life.

CONCLUSION

The value of operative intervention for bowel obstruction in patients with cancer is derived from the possibility of a benign cause, not alleviation of the consequences of carcinomatosis.

摘要

目的

确定手术治疗复发性腹部肿瘤所致肠梗阻患者的价值。

设计

回顾性病例分析。

地点

康涅狄格大学健康中心,法明顿。

患者

1987年11月1日至1995年6月30日期间收治的98例诊断为肠梗阻和恶性肿瘤的患者。

结果

分析了75例在恶性肿瘤诊断后5年内发生肠梗阻的患者的数据。46例(61%)接受了手术治疗,29例(39%)接受了非手术治疗。手术组包括32例(70%)梗阻由癌性腹膜炎引起的患者;这32例患者中有6例(19%)曾至少有1次因肠梗阻住院治疗。他们的住院死亡率为22%,平均住院21天,出院后存活7±6个月(均值±标准差);5例(16%)至少有1次术后肠梗阻需住院治疗。出院后,53%的患者生活质量为优或良(回顾性评估)。非手术组的29例患者中,16例(55%)有癌性腹膜炎。这16例患者的住院死亡率为38%(16例中有6例),平均住院10天,平均存活13±9个月;3例(19%)至少有1次复发性肠梗阻需住院治疗。出院后,6例(37%)患者生活质量为优或良。

结论

手术干预癌症患者肠梗阻的价值源于存在良性病因的可能性,而非缓解癌性腹膜炎的后果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验